Evidence map›Paper›PMID 33080838›Full record

ReviewBiomolecules2020

Ubiquitomics: An Overview and Future.

George Vere, Rachel Kealy, Benedikt M Kessler, Adan Pinto-Fernandez

Open access · goldAbstract readReview
In one paragraph

Review in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 115 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Tracking E2-specific substrates.Nature chemical biology · 2025
    Article
  5. Article
  6. Review
  7. The Ubiquitin Tale: Current Strategies and Future Challenges.ACS pharmacology & translational science · 2024
    Review
  8. Article
  9. An expanded lexicon for the ubiquitin code.Nature reviews. Molecular cell biology · 2023
    Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. USP2-Related Cellular Signaling and Consequent Pathophysiological Outcomes.International journal of molecular sciences · 2021
    Review
  18. Evolution and Adaptation ofBiomolecules · 2021
    Review
  19. Tools for Decoding Ubiquitin Signaling in DNA Repair.Frontiers in cell and developmental biology · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

George VereTarget Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.ORCID 0000-0002-1154-5212
Rachel KealySt Anne's College, University of Oxford, Oxford OX2 6HS, UK.ORCID 0000-0001-8191-1444
Benedikt M KesslerTarget Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.
Adan Pinto-FernandezTarget Discovery Institute, Nuffield Department of Medicine, University of Oxford, Oxford OX3 7FZ, UK.ORCID 0000-0003-1693-9664
University of Oxford · GBAcademy of Medical Sciences · GB

Funding

Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Science (CIFMS) 2018-I2M-2-002EPSRC EP/N034295/1Pfizer Inc N/A
6 · The paper itself

Abstract

Covalent attachment of ubiquitin, a small globular polypeptide, to protein substrates is a key post-translational modification that determines the fate, function, and turnover of most cellular proteins. Ubiquitin modification exists as mono- or polyubiquitin chains involving multiple ways how ubiquitin C-termini are connected to lysine, perhaps other amino acid side chains, and N-termini of proteins, often including branching of the ubiquitin chains. Understanding this enormous complexity in protein ubiquitination, the so-called 'ubiquitin code', in combination with the ∼1000 enzymes involved in controlling ubiquitin recognition, conjugation, and deconjugation, calls for novel developments in analytical techniques. Here, we review different headways in the field mainly driven by mass spectrometry and chemical biology, referred to as "ubiquitomics", aiming to understand this system's biological diversity.

Indexed as

HumansPolyubiquitinProtein Processing, Post-TranslationalSignal TransductionUbiquitinUbiquitinationUbiquitin-Protein LigasesPolyubiquitinUbiquitinUbiquitin-Protein Ligasesmass spectrometryproteomicsubiquitinubiquitomeubiquitomics

Identifiers

PMID33080838
PMCPMC7603029
OpenAlexW3093217454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.